Harvard Chip Writes ‘Living Code’ With Electricity

Illustration of a human head with DNA strands and hands reaching towards it

A Harvard team just turned a silicon chip into a DNA writing machine — and what it encoded inside those strands could change how we store data, make medicines, and build genes.

Story Snapshot

Harvard researchers wrote 64 different DNA sequences at the same time on a single semiconductor chip, setting a new record for enzymatic DNA synthesis.
The chip uses tiny electric currents to control acidity at 64 separate spots, triggering DNA strand growth one chemical letter at a time.
The team proved it works by encoding a 169-byte text message into the synthesized DNA strands.
The method uses water-based chemistry instead of the toxic solvents that dominate DNA synthesis today, which is a meaningful step toward cleaner production.

Why Writing DNA Has Always Been Hard

Most people know DNA as the molecule that carries your genetic code. Fewer people know that scientists can write it from scratch. That ability sits at the heart of modern medicine, genetic research, and the emerging field of DNA data storage. But writing DNA is slow, expensive, and chemically messy. The dominant method, called phosphoramidite chemistry, has been the standard since the 1980s. It works well, but it relies on harsh organic solvents that create toxic waste with every run.

Enzymatic methods — which use proteins called enzymes to build DNA strands the way your own cells do — have promised a cleaner path for decades. The catch has always been scale. Until now, the best enzymatic platforms could handle roughly a dozen sequences at once. That ceiling made them interesting in the lab but impractical for the kind of parallel production that medicine and data storage actually need.

What the Harvard Chip Actually Does

The chip published in Nature Electronics in July 2026 by Harvard professor Donhee Ham and his team does something genuinely new. It places 64 individual synthesis sites on a semiconductor surface. At each site, a small electric current shifts the local acidity level. That shift triggers an enzyme to add one DNA building block — called a nucleotide — to a growing strand. Repeat the process, site by site, and you build sequences letter by letter, all 64 running at the same time.

Each sequence the chip produced reached up to 39 nucleotides in length. To prove the system works as more than a lab curiosity, the team encoded a 169-byte text message into the synthesized DNA strands. That demonstration matters because DNA data storage is a serious field. DNA can hold enormous amounts of information in an incredibly small space, and it can last for thousands of years under the right conditions. Showing that a chip can write readable data into DNA is not a small thing.

The Limits That Still Matter

The 39-nucleotide ceiling is a real constraint worth understanding. Many practical applications in gene assembly require sequences that are much longer. Standard gene-building workflows often stitch together short pieces, so the chip’s output could still feed into those pipelines. But it is not yet a tool for writing full genes in one pass. The Harvard team has not published error rate data or sequence fidelity numbers, which means outside researchers cannot yet judge how clean or reliable each synthesized strand actually is.

No major biotech firm has announced a partnership or licensing deal with the Harvard team. That silence is not damning — early-stage academic research rarely lands commercial deals on publication day — but it is worth watching. Companies like Twist Bioscience have already built semiconductor-based enzymatic platforms of their own. The competitive landscape is real, and Harvard’s chip will need independent replication and yield data before industry moves toward it.

Why This Moment in DNA Synthesis History Is Different

Every decade or so, a new DNA synthesis method arrives with bold claims. Phosphoramidite chemistry survived its critics because it delivered on fidelity and scale. Enzymatic methods have repeatedly promised to replace it and repeatedly fallen short on yield and accuracy. The Harvard chip does not erase those concerns. But it does something prior enzymatic platforms did not: it integrates the synthesis control directly into the semiconductor itself. The chip is not just a container for chemistry — it is the instrument running it.

That integration matters because semiconductor manufacturing is one of the most refined and scalable industries on earth. If enzymatic DNA synthesis can be made to run reliably on a chip architecture, the path to mass production becomes far more plausible than it ever was with stand-alone enzymatic reactors. The science still needs to prove itself at scale. But the architecture behind this approach is genuinely different from what came before, and that is not a small distinction.